Impact of amiodarone and cisapride on simulated human ventricular electrophysiology and electrocardiograms

Amiodarone and cisapride are both known to prolong the QT interval, yet the two drugs have different effects on arrhythmia. Cisapride can cause torsades de pointes while amiodarone is found to be anti-arrhythmic. A computational model was used to investigate the action of these two drugs. In a bioph...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Europace (London, England) England), 2012-11, Vol.14 Suppl 5 (suppl 5), p.v90-v96
Hauptverfasser: Wilhelms, Mathias, Rombach, Christian, Scholz, Eberhard P, Dössel, Olaf, Seemann, Gunnar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page v96
container_issue suppl 5
container_start_page v90
container_title Europace (London, England)
container_volume 14 Suppl 5
creator Wilhelms, Mathias
Rombach, Christian
Scholz, Eberhard P
Dössel, Olaf
Seemann, Gunnar
description Amiodarone and cisapride are both known to prolong the QT interval, yet the two drugs have different effects on arrhythmia. Cisapride can cause torsades de pointes while amiodarone is found to be anti-arrhythmic. A computational model was used to investigate the action of these two drugs. In a biophysically detailed model, the ion current conductivities affected by both drugs were reduced in order to simulate the pharmacological effects in healthy and ischaemic cells. Furthermore, restitution curves of the action potential duration (APD), effective refractory period, conduction velocity, wavelength, and the vulnerable window were determined in a one-dimensional (1D) tissue strand. Moreover, cardiac excitation propagation was computed in a 3D model of healthy ventricles. The corresponding body surface potentials were calculated and standard 12-lead electrocardiograms were derived. Both cisapride and amiodarone caused a prolongation of the QT interval and the refractory period. However, cisapride did not significantly alter the conduction-related properties, such as e.g. the wavelength or vulnerable window, whereas amiodarone had a larger impact on them. It slightly flattened the APD restitution slope and furthermore reduced the conduction velocity and wavelength. Both drugs show similar prolongation of the QT interval, although they present different electrophysiological properties in the single-cell as well as in tissue simulations of cardiac excitation propagation. These computer simulations help to better understand the underlying mechanisms responsible for the initiation or termination of arrhythmias caused by amiodarone and cisapride.
doi_str_mv 10.1093/europace/eus281
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1125248326</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1125248326</sourcerecordid><originalsourceid>FETCH-LOGICAL-c338t-f623b140400e54ad06eb6d58e2d85310d01ef11b8a51a1f0f353a106484619d13</originalsourceid><addsrcrecordid>eNo9UD1PwzAUtBCIlsLMhjyyhL5nxyEZUcVHpUosMEeO_dKmSuJiJ0j99xjaMr3T6e507xi7RXhAKOScRu922lAEQeR4xqaopEgEFOI8YiiKRKEoJuwqhC0APIpCXbKJkAhpIWDKtssu-gfuaq67xlntXU9c95abJuidbyxx1_PQdGOrB7J8M3a659_UD74xkfOcWjJDrLHZh8a1br3_sx9Zo71t3NrrLlyzi1q3gW6Od8Y-X54_Fm_J6v11uXhaJUbKfEjqTMgKU0gBSKXaQkZVZlVOwuYq9raAVCNWuVaosYZaKqkRsjRPMywsyhm7P-TuvPsaKQxl1wRDbat7cmMoEYUSaS5FFqXzg9R4F4Knuowfd9rvS4Tyd-DyNHB5GDg67o7hY9WR_defFpU_8F17iA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1125248326</pqid></control><display><type>article</type><title>Impact of amiodarone and cisapride on simulated human ventricular electrophysiology and electrocardiograms</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford Journals Open Access Collection</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Wilhelms, Mathias ; Rombach, Christian ; Scholz, Eberhard P ; Dössel, Olaf ; Seemann, Gunnar</creator><creatorcontrib>Wilhelms, Mathias ; Rombach, Christian ; Scholz, Eberhard P ; Dössel, Olaf ; Seemann, Gunnar</creatorcontrib><description>Amiodarone and cisapride are both known to prolong the QT interval, yet the two drugs have different effects on arrhythmia. Cisapride can cause torsades de pointes while amiodarone is found to be anti-arrhythmic. A computational model was used to investigate the action of these two drugs. In a biophysically detailed model, the ion current conductivities affected by both drugs were reduced in order to simulate the pharmacological effects in healthy and ischaemic cells. Furthermore, restitution curves of the action potential duration (APD), effective refractory period, conduction velocity, wavelength, and the vulnerable window were determined in a one-dimensional (1D) tissue strand. Moreover, cardiac excitation propagation was computed in a 3D model of healthy ventricles. The corresponding body surface potentials were calculated and standard 12-lead electrocardiograms were derived. Both cisapride and amiodarone caused a prolongation of the QT interval and the refractory period. However, cisapride did not significantly alter the conduction-related properties, such as e.g. the wavelength or vulnerable window, whereas amiodarone had a larger impact on them. It slightly flattened the APD restitution slope and furthermore reduced the conduction velocity and wavelength. Both drugs show similar prolongation of the QT interval, although they present different electrophysiological properties in the single-cell as well as in tissue simulations of cardiac excitation propagation. These computer simulations help to better understand the underlying mechanisms responsible for the initiation or termination of arrhythmias caused by amiodarone and cisapride.</description><identifier>ISSN: 1099-5129</identifier><identifier>EISSN: 1532-2092</identifier><identifier>DOI: 10.1093/europace/eus281</identifier><identifier>PMID: 23104920</identifier><language>eng</language><publisher>England</publisher><subject>Amiodarone - administration &amp; dosage ; Anti-Arrhythmia Agents - administration &amp; dosage ; Arrhythmias, Cardiac - drug therapy ; Arrhythmias, Cardiac - physiopathology ; Cisapride - administration &amp; dosage ; Computer Simulation ; Drug Therapy, Computer-Assisted - methods ; Electrocardiography - drug effects ; Heart Conduction System - drug effects ; Heart Conduction System - physiopathology ; Heart Ventricles - drug effects ; Heart Ventricles - physiopathology ; Humans ; Models, Cardiovascular ; Serotonin Receptor Agonists - administration &amp; dosage</subject><ispartof>Europace (London, England), 2012-11, Vol.14 Suppl 5 (suppl 5), p.v90-v96</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c338t-f623b140400e54ad06eb6d58e2d85310d01ef11b8a51a1f0f353a106484619d13</citedby><cites>FETCH-LOGICAL-c338t-f623b140400e54ad06eb6d58e2d85310d01ef11b8a51a1f0f353a106484619d13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23104920$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wilhelms, Mathias</creatorcontrib><creatorcontrib>Rombach, Christian</creatorcontrib><creatorcontrib>Scholz, Eberhard P</creatorcontrib><creatorcontrib>Dössel, Olaf</creatorcontrib><creatorcontrib>Seemann, Gunnar</creatorcontrib><title>Impact of amiodarone and cisapride on simulated human ventricular electrophysiology and electrocardiograms</title><title>Europace (London, England)</title><addtitle>Europace</addtitle><description>Amiodarone and cisapride are both known to prolong the QT interval, yet the two drugs have different effects on arrhythmia. Cisapride can cause torsades de pointes while amiodarone is found to be anti-arrhythmic. A computational model was used to investigate the action of these two drugs. In a biophysically detailed model, the ion current conductivities affected by both drugs were reduced in order to simulate the pharmacological effects in healthy and ischaemic cells. Furthermore, restitution curves of the action potential duration (APD), effective refractory period, conduction velocity, wavelength, and the vulnerable window were determined in a one-dimensional (1D) tissue strand. Moreover, cardiac excitation propagation was computed in a 3D model of healthy ventricles. The corresponding body surface potentials were calculated and standard 12-lead electrocardiograms were derived. Both cisapride and amiodarone caused a prolongation of the QT interval and the refractory period. However, cisapride did not significantly alter the conduction-related properties, such as e.g. the wavelength or vulnerable window, whereas amiodarone had a larger impact on them. It slightly flattened the APD restitution slope and furthermore reduced the conduction velocity and wavelength. Both drugs show similar prolongation of the QT interval, although they present different electrophysiological properties in the single-cell as well as in tissue simulations of cardiac excitation propagation. These computer simulations help to better understand the underlying mechanisms responsible for the initiation or termination of arrhythmias caused by amiodarone and cisapride.</description><subject>Amiodarone - administration &amp; dosage</subject><subject>Anti-Arrhythmia Agents - administration &amp; dosage</subject><subject>Arrhythmias, Cardiac - drug therapy</subject><subject>Arrhythmias, Cardiac - physiopathology</subject><subject>Cisapride - administration &amp; dosage</subject><subject>Computer Simulation</subject><subject>Drug Therapy, Computer-Assisted - methods</subject><subject>Electrocardiography - drug effects</subject><subject>Heart Conduction System - drug effects</subject><subject>Heart Conduction System - physiopathology</subject><subject>Heart Ventricles - drug effects</subject><subject>Heart Ventricles - physiopathology</subject><subject>Humans</subject><subject>Models, Cardiovascular</subject><subject>Serotonin Receptor Agonists - administration &amp; dosage</subject><issn>1099-5129</issn><issn>1532-2092</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9UD1PwzAUtBCIlsLMhjyyhL5nxyEZUcVHpUosMEeO_dKmSuJiJ0j99xjaMr3T6e507xi7RXhAKOScRu922lAEQeR4xqaopEgEFOI8YiiKRKEoJuwqhC0APIpCXbKJkAhpIWDKtssu-gfuaq67xlntXU9c95abJuidbyxx1_PQdGOrB7J8M3a659_UD74xkfOcWjJDrLHZh8a1br3_sx9Zo71t3NrrLlyzi1q3gW6Od8Y-X54_Fm_J6v11uXhaJUbKfEjqTMgKU0gBSKXaQkZVZlVOwuYq9raAVCNWuVaosYZaKqkRsjRPMywsyhm7P-TuvPsaKQxl1wRDbat7cmMoEYUSaS5FFqXzg9R4F4Knuowfd9rvS4Tyd-DyNHB5GDg67o7hY9WR_defFpU_8F17iA</recordid><startdate>201211</startdate><enddate>201211</enddate><creator>Wilhelms, Mathias</creator><creator>Rombach, Christian</creator><creator>Scholz, Eberhard P</creator><creator>Dössel, Olaf</creator><creator>Seemann, Gunnar</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201211</creationdate><title>Impact of amiodarone and cisapride on simulated human ventricular electrophysiology and electrocardiograms</title><author>Wilhelms, Mathias ; Rombach, Christian ; Scholz, Eberhard P ; Dössel, Olaf ; Seemann, Gunnar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c338t-f623b140400e54ad06eb6d58e2d85310d01ef11b8a51a1f0f353a106484619d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Amiodarone - administration &amp; dosage</topic><topic>Anti-Arrhythmia Agents - administration &amp; dosage</topic><topic>Arrhythmias, Cardiac - drug therapy</topic><topic>Arrhythmias, Cardiac - physiopathology</topic><topic>Cisapride - administration &amp; dosage</topic><topic>Computer Simulation</topic><topic>Drug Therapy, Computer-Assisted - methods</topic><topic>Electrocardiography - drug effects</topic><topic>Heart Conduction System - drug effects</topic><topic>Heart Conduction System - physiopathology</topic><topic>Heart Ventricles - drug effects</topic><topic>Heart Ventricles - physiopathology</topic><topic>Humans</topic><topic>Models, Cardiovascular</topic><topic>Serotonin Receptor Agonists - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wilhelms, Mathias</creatorcontrib><creatorcontrib>Rombach, Christian</creatorcontrib><creatorcontrib>Scholz, Eberhard P</creatorcontrib><creatorcontrib>Dössel, Olaf</creatorcontrib><creatorcontrib>Seemann, Gunnar</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Europace (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wilhelms, Mathias</au><au>Rombach, Christian</au><au>Scholz, Eberhard P</au><au>Dössel, Olaf</au><au>Seemann, Gunnar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of amiodarone and cisapride on simulated human ventricular electrophysiology and electrocardiograms</atitle><jtitle>Europace (London, England)</jtitle><addtitle>Europace</addtitle><date>2012-11</date><risdate>2012</risdate><volume>14 Suppl 5</volume><issue>suppl 5</issue><spage>v90</spage><epage>v96</epage><pages>v90-v96</pages><issn>1099-5129</issn><eissn>1532-2092</eissn><abstract>Amiodarone and cisapride are both known to prolong the QT interval, yet the two drugs have different effects on arrhythmia. Cisapride can cause torsades de pointes while amiodarone is found to be anti-arrhythmic. A computational model was used to investigate the action of these two drugs. In a biophysically detailed model, the ion current conductivities affected by both drugs were reduced in order to simulate the pharmacological effects in healthy and ischaemic cells. Furthermore, restitution curves of the action potential duration (APD), effective refractory period, conduction velocity, wavelength, and the vulnerable window were determined in a one-dimensional (1D) tissue strand. Moreover, cardiac excitation propagation was computed in a 3D model of healthy ventricles. The corresponding body surface potentials were calculated and standard 12-lead electrocardiograms were derived. Both cisapride and amiodarone caused a prolongation of the QT interval and the refractory period. However, cisapride did not significantly alter the conduction-related properties, such as e.g. the wavelength or vulnerable window, whereas amiodarone had a larger impact on them. It slightly flattened the APD restitution slope and furthermore reduced the conduction velocity and wavelength. Both drugs show similar prolongation of the QT interval, although they present different electrophysiological properties in the single-cell as well as in tissue simulations of cardiac excitation propagation. These computer simulations help to better understand the underlying mechanisms responsible for the initiation or termination of arrhythmias caused by amiodarone and cisapride.</abstract><cop>England</cop><pmid>23104920</pmid><doi>10.1093/europace/eus281</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1099-5129
ispartof Europace (London, England), 2012-11, Vol.14 Suppl 5 (suppl 5), p.v90-v96
issn 1099-5129
1532-2092
language eng
recordid cdi_proquest_miscellaneous_1125248326
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford Journals Open Access Collection; PubMed Central; Alma/SFX Local Collection
subjects Amiodarone - administration & dosage
Anti-Arrhythmia Agents - administration & dosage
Arrhythmias, Cardiac - drug therapy
Arrhythmias, Cardiac - physiopathology
Cisapride - administration & dosage
Computer Simulation
Drug Therapy, Computer-Assisted - methods
Electrocardiography - drug effects
Heart Conduction System - drug effects
Heart Conduction System - physiopathology
Heart Ventricles - drug effects
Heart Ventricles - physiopathology
Humans
Models, Cardiovascular
Serotonin Receptor Agonists - administration & dosage
title Impact of amiodarone and cisapride on simulated human ventricular electrophysiology and electrocardiograms
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T05%3A09%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20amiodarone%20and%20cisapride%20on%20simulated%20human%20ventricular%20electrophysiology%20and%20electrocardiograms&rft.jtitle=Europace%20(London,%20England)&rft.au=Wilhelms,%20Mathias&rft.date=2012-11&rft.volume=14%20Suppl%205&rft.issue=suppl%205&rft.spage=v90&rft.epage=v96&rft.pages=v90-v96&rft.issn=1099-5129&rft.eissn=1532-2092&rft_id=info:doi/10.1093/europace/eus281&rft_dat=%3Cproquest_cross%3E1125248326%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1125248326&rft_id=info:pmid/23104920&rfr_iscdi=true